Atlas Trials

Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

Clinical trial NCT00129922 · COMPLETED

Trial details

NCT number
NCT00129922
Sponsor
Spanish Breast Cancer Research Group
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
1999-11-01
Primary completion
2005-12-01
Enrollment
1289

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.